期刊文献+

关于脓毒症的发生机制与识别和干预 被引量:13

Pathogenesis,diagnosis,and management for sepsis:update progress and scientific problems
原文传递
导出
摘要 脓毒症是由不同病原体及其毒性因子引起宿主对感染的反应失调,并导致多器官功能障碍。脓毒症发生机制复杂,涉及表观遗传重编程、代谢衰竭、免疫功能障碍、神经-内分泌紊乱、凝血异常、组织或器官衰竭等诸多科学问题。本文旨在了解脓毒症的宿主反应和发病机制,进而根据脓毒症异质性特点,探索精准诊疗的预警标志物和干预靶标,最终降低脓毒症的发病率和病死率。 Sepsis is caused by various pathogens and toxic factors,which can lead to multiple organ dysfunction.The underlying mechanism of sepsis appears to be complex,involving epigenetic reprogramming,metabolic failure,immune dysfunction,neuroendocrine system disorders,coagulation abnormalities,tissue or organ failure,and many other scientific issues.With our deep understanding of the host reaction and development of sepsis,it is of great significance to explore predicative markers and therapeutic targets according to the atypical characteristics of sepsis,thereby contributing to the reduction of morbidity and mortality of sepsis.
作者 栾樱译 祝筱梅 姚咏明 Luan Yingyi;Zhu Xiaomei;Yao Yongming(Translational Medicine Research Center,Medical Innovation Research Division and the Fourth Medical Center of PLA General Hospital,Beijing 100048,China)
出处 《中华危重病急救医学》 CAS CSCD 北大核心 2021年第5期513-516,共4页 Chinese Critical Care Medicine
基金 国家自然科学基金(81730057,81873943)。
关键词 脓毒症 调控机制 预警 治疗 Sepsis Regulatory mechanism Prediction Treatment
  • 相关文献

参考文献4

二级参考文献54

  • 1奚晶晶,王红,杨钧.降钙素原在脓毒症患者中的动态变化及中药干预的影响[J].中国中西医结合急救杂志,2007,14(6):327-329. 被引量:40
  • 2Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 [J]. Crit Care Med, 2013, 41 (2): 580-637.
  • 3Briegel J, Mohnle p, Dellinger RP, et al. International guidelines of the Surviving Sepsis Campaign : update 2012 [ J ]. Anaesthesist, 2013, 62 ( 4 ) : 304-309.
  • 4Christaki E, Anyfanti P, Opal SM. Immunomodulatory therapy for sepsis: an update [J]. Expert Rev Anti Infect Ther, 2011, 9 (11): 1013-1033.
  • 5Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis Is individualized immuno-modulatory therapy the answer [J]. Virulence, 2014, 5 (1): 45-56.
  • 6Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure [ J ]. JAMA, 2011, 306 (23) : 2594-2605.
  • 7de Pablo R, Monserrat J, Pfieto A, et al. Role of circulating lymphocytes in patients with sepsis [ J]. Biomed Res Int, 2014, 2014: 671087.
  • 8Wiersinga WJ, Leopold SJ, Cranendonk DR, et al. Host innate immune responses to sepsis [J]. Virulence, 2014, 5 (1) : 36- 44. 5436.
  • 9Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy [J]. Nat Rev Immunol, 2013, 13 (12): 862-874.
  • 10Almansa R, Wain J, Tamayo E, et al. Immunological monitoring to prevent and treat sepsis [ J]. Crit Care, 2013, 17 ( 1 ) : 109.

共引文献95

同被引文献130

引证文献13

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部